Report Overview:
Anthrax is a serious disease that can affect both animals and humans. It is caused by bacteria called Bacillus anthracis. People can get anthrax from contact with infected animals, wool, meat, or hides.Anthrax vaccine protects against anthrax disease. Anthrax vaccine was licensed in 1970.Based on limited but sound evidence, the vaccine protects against both cutaneous (skin) and inhalation anthrax.
The Global Anthrax Vaccines Market Size was estimated at USD 710.47 million in 2023 and is projected to reach USD 1102.61 million by 2029, exhibiting a CAGR of 7.60% during the forecast period.
This report provides a deep insight into the global Anthrax Vaccines market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter?s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Anthrax Vaccines Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Anthrax Vaccines market in any manner.
Global Anthrax Vaccines Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Emergent BioSolutions
Merial
Merck
Zoetis
Bayer Sanidad Animal
Colorado Serum
PharmAthene
Tiankang
Biog?nesis-Bago
CAVAC
Rosenbusch
Agrovet
Vecol
CVCRI
IVPM
Prondil
CDV
Indian Immunologicals
Botswana Vaccine Institute
Ceva Sant? Animale
Intervac
JOVAC
Market Segmentation (by Type)
Live Vaccines
Cell free PA Vaccines
Market Segmentation (by Application)
Human Use
Animal Use
Geographic Segmentation
? North America (USA, Canada, Mexico)
? Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
? Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
? South America (Brazil, Argentina, Columbia, Rest of South America)
? The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
? Industry drivers, restraints, and opportunities covered in the study
? Neutral perspective on the market performance
? Recent industry trends and developments
? Competitive landscape & strategies of key players
? Potential & niche segments and regions exhibiting promising growth covered
? Historical, current, and projected market size, in terms of value
? In-depth analysis of the Anthrax Vaccines Market
? Overview of the regional outlook of the Anthrax Vaccines Market:
Key Reasons to Buy this Report:
? Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
? This enables you to anticipate market changes to remain ahead of your competitors
? You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
? The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
? Provision of market value (USD Billion) data for each segment and sub-segment
? Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
? Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
? Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
? Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
? The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
? Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
? Provides insight into the market through Value Chain
? Market dynamics scenario, along with growth opportunities of the market in the years to come
? 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Anthrax Vaccines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Anthrax Vaccines
1.2 Key Market Segments
1.2.1 Anthrax Vaccines Segment by Type
1.2.2 Anthrax Vaccines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Anthrax Vaccines Market Overview
2.1 Global Market Overview
2.1.1 Global Anthrax Vaccines Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Anthrax Vaccines Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Anthrax Vaccines Market Competitive Landscape
3.1 Global Anthrax Vaccines Sales by Manufacturers (2019-2024)
3.2 Global Anthrax Vaccines Revenue Market Share by Manufacturers (2019-2024)
3.3 Anthrax Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Anthrax Vaccines Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Anthrax Vaccines Sales Sites, Area Served, Product Type
3.6 Anthrax Vaccines Market Competitive Situation and Trends
3.6.1 Anthrax Vaccines Market Concentration Rate
3.6.2 Global 5 and 10 Largest Anthrax Vaccines Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Anthrax Vaccines Industry Chain Analysis
4.1 Anthrax Vaccines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Anthrax Vaccines Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Anthrax Vaccines Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Anthrax Vaccines Sales Market Share by Type (2019-2024)
6.3 Global Anthrax Vaccines Market Size Market Share by Type (2019-2024)
6.4 Global Anthrax Vaccines Price by Type (2019-2024)
7 Anthrax Vaccines Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Anthrax Vaccines Market Sales by Application (2019-2024)
7.3 Global Anthrax Vaccines Market Size (M USD) by Application (2019-2024)
7.4 Global Anthrax Vaccines Sales Growth Rate by Application (2019-2024)
8 Anthrax Vaccines Market Segmentation by Region
8.1 Global Anthrax Vaccines Sales by Region
8.1.1 Global Anthrax Vaccines Sales by Region
8.1.2 Global Anthrax Vaccines Sales Market Share by Region
8.2 North America
8.2.1 North America Anthrax Vaccines Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Anthrax Vaccines Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Anthrax Vaccines Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Anthrax Vaccines Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Anthrax Vaccines Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Emergent BioSolutions
9.1.1 Emergent BioSolutions Anthrax Vaccines Basic Information
9.1.2 Emergent BioSolutions Anthrax Vaccines Product Overview
9.1.3 Emergent BioSolutions Anthrax Vaccines Product Market Performance
9.1.4 Emergent BioSolutions Business Overview
9.1.5 Emergent BioSolutions Anthrax Vaccines SWOT Analysis
9.1.6 Emergent BioSolutions Recent Developments
9.2 Merial
9.2.1 Merial Anthrax Vaccines Basic Information
9.2.2 Merial Anthrax Vaccines Product Overview
9.2.3 Merial Anthrax Vaccines Product Market Performance
9.2.4 Merial Business Overview
9.2.5 Merial Anthrax Vaccines SWOT Analysis
9.2.6 Merial Recent Developments
9.3 Merck
9.3.1 Merck Anthrax Vaccines Basic Information
9.3.2 Merck Anthrax Vaccines Product Overview
9.3.3 Merck Anthrax Vaccines Product Market Performance
9.3.4 Merck Anthrax Vaccines SWOT Analysis
9.3.5 Merck Business Overview
9.3.6 Merck Recent Developments
9.4 Zoetis
9.4.1 Zoetis Anthrax Vaccines Basic Information
9.4.2 Zoetis Anthrax Vaccines Product Overview
9.4.3 Zoetis Anthrax Vaccines Product Market Performance
9.4.4 Zoetis Business Overview
9.4.5 Zoetis Recent Developments
9.5 Bayer Sanidad Animal
9.5.1 Bayer Sanidad Animal Anthrax Vaccines Basic Information
9.5.2 Bayer Sanidad Animal Anthrax Vaccines Product Overview
9.5.3 Bayer Sanidad Animal Anthrax Vaccines Product Market Performance
9.5.4 Bayer Sanidad Animal Business Overview
9.5.5 Bayer Sanidad Animal Recent Developments
9.6 Colorado Serum
9.6.1 Colorado Serum Anthrax Vaccines Basic Information
9.6.2 Colorado Serum Anthrax Vaccines Product Overview
9.6.3 Colorado Serum Anthrax Vaccines Product Market Performance
9.6.4 Colorado Serum Business Overview
9.6.5 Colorado Serum Recent Developments
9.7 PharmAthene
9.7.1 PharmAthene Anthrax Vaccines Basic Information
9.7.2 PharmAthene Anthrax Vaccines Product Overview
9.7.3 PharmAthene Anthrax Vaccines Product Market Performance
9.7.4 PharmAthene Business Overview
9.7.5 PharmAthene Recent Developments
9.8 Tiankang
9.8.1 Tiankang Anthrax Vaccines Basic Information
9.8.2 Tiankang Anthrax Vaccines Product Overview
9.8.3 Tiankang Anthrax Vaccines Product Market Performance
9.8.4 Tiankang Business Overview
9.8.5 Tiankang Recent Developments
9.9 Biog?nesis-Bago
9.9.1 Biog?nesis-Bago Anthrax Vaccines Basic Information
9.9.2 Biog?nesis-Bago Anthrax Vaccines Product Overview
9.9.3 Biog?nesis-Bago Anthrax Vaccines Product Market Performance
9.9.4 Biog?nesis-Bago Business Overview
9.9.5 Biog?nesis-Bago Recent Developments
9.10 CAVAC
9.10.1 CAVAC Anthrax Vaccines Basic Information
9.10.2 CAVAC Anthrax Vaccines Product Overview
9.10.3 CAVAC Anthrax Vaccines Product Market Performance
9.10.4 CAVAC Business Overview
9.10.5 CAVAC Recent Developments
9.11 Rosenbusch
9.11.1 Rosenbusch Anthrax Vaccines Basic Information
9.11.2 Rosenbusch Anthrax Vaccines Product Overview
9.11.3 Rosenbusch Anthrax Vaccines Product Market Performance
9.11.4 Rosenbusch Business Overview
9.11.5 Rosenbusch Recent Developments
9.12 Agrovet
9.12.1 Agrovet Anthrax Vaccines Basic Information
9.12.2 Agrovet Anthrax Vaccines Product Overview
9.12.3 Agrovet Anthrax Vaccines Product Market Performance
9.12.4 Agrovet Business Overview
9.12.5 Agrovet Recent Developments
9.13 Vecol
9.13.1 Vecol Anthrax Vaccines Basic Information
9.13.2 Vecol Anthrax Vaccines Product Overview
9.13.3 Vecol Anthrax Vaccines Product Market Performance
9.13.4 Vecol Business Overview
9.13.5 Vecol Recent Developments
9.14 CVCRI
9.14.1 CVCRI Anthrax Vaccines Basic Information
9.14.2 CVCRI Anthrax Vaccines Product Overview
9.14.3 CVCRI Anthrax Vaccines Product Market Performance
9.14.4 CVCRI Business Overview
9.14.5 CVCRI Recent Developments
9.15 IVPM
9.15.1 IVPM Anthrax Vaccines Basic Information
9.15.2 IVPM Anthrax Vaccines Product Overview
9.15.3 IVPM Anthrax Vaccines Product Market Performance
9.15.4 IVPM Business Overview
9.15.5 IVPM Recent Developments
9.16 Prondil
9.16.1 Prondil Anthrax Vaccines Basic Information
9.16.2 Prondil Anthrax Vaccines Product Overview
9.16.3 Prondil Anthrax Vaccines Product Market Performance
9.16.4 Prondil Business Overview
9.16.5 Prondil Recent Developments
9.17 CDV
9.17.1 CDV Anthrax Vaccines Basic Information
9.17.2 CDV Anthrax Vaccines Product Overview
9.17.3 CDV Anthrax Vaccines Product Market Performance
9.17.4 CDV Business Overview
9.17.5 CDV Recent Developments
9.18 Indian Immunologicals
9.18.1 Indian Immunologicals Anthrax Vaccines Basic Information
9.18.2 Indian Immunologicals Anthrax Vaccines Product Overview
9.18.3 Indian Immunologicals Anthrax Vaccines Product Market Performance
9.18.4 Indian Immunologicals Business Overview
9.18.5 Indian Immunologicals Recent Developments
9.19 Botswana Vaccine Institute
9.19.1 Botswana Vaccine Institute Anthrax Vaccines Basic Information
9.19.2 Botswana Vaccine Institute Anthrax Vaccines Product Overview
9.19.3 Botswana Vaccine Institute Anthrax Vaccines Product Market Performance
9.19.4 Botswana Vaccine Institute Business Overview
9.19.5 Botswana Vaccine Institute Recent Developments
9.20 Ceva Sant? Animale
9.20.1 Ceva Sant? Animale Anthrax Vaccines Basic Information
9.20.2 Ceva Sant? Animale Anthrax Vaccines Product Overview
9.20.3 Ceva Sant? Animale Anthrax Vaccines Product Market Performance
9.20.4 Ceva Sant? Animale Business Overview
9.20.5 Ceva Sant? Animale Recent Developments
9.21 Intervac
9.21.1 Intervac Anthrax Vaccines Basic Information
9.21.2 Intervac Anthrax Vaccines Product Overview
9.21.3 Intervac Anthrax Vaccines Product Market Performance
9.21.4 Intervac Business Overview
9.21.5 Intervac Recent Developments
9.22 JOVAC
9.22.1 JOVAC Anthrax Vaccines Basic Information
9.22.2 JOVAC Anthrax Vaccines Product Overview
9.22.3 JOVAC Anthrax Vaccines Product Market Performance
9.22.4 JOVAC Business Overview
9.22.5 JOVAC Recent Developments
10 Anthrax Vaccines Market Forecast by Region
10.1 Global Anthrax Vaccines Market Size Forecast
10.2 Global Anthrax Vaccines Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Anthrax Vaccines Market Size Forecast by Country
10.2.3 Asia Pacific Anthrax Vaccines Market Size Forecast by Region
10.2.4 South America Anthrax Vaccines Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Anthrax Vaccines by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Anthrax Vaccines Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Anthrax Vaccines by Type (2025-2030)
11.1.2 Global Anthrax Vaccines Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Anthrax Vaccines by Type (2025-2030)
11.2 Global Anthrax Vaccines Market Forecast by Application (2025-2030)
11.2.1 Global Anthrax Vaccines Sales (Kilotons) Forecast by Application
11.2.2 Global Anthrax Vaccines Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Anthrax Vaccines Market Size Comparison by Region (M USD)
Table 5. Global Anthrax Vaccines Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Anthrax Vaccines Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Anthrax Vaccines Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Anthrax Vaccines Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anthrax Vaccines as of 2022)
Table 10. Global Market Anthrax Vaccines Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Anthrax Vaccines Sales Sites and Area Served
Table 12. Manufacturers Anthrax Vaccines Product Type
Table 13. Global Anthrax Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Anthrax Vaccines
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Anthrax Vaccines Market Challenges
Table 22. Global Anthrax Vaccines Sales by Type (Kilotons)
Table 23. Global Anthrax Vaccines Market Size by Type (M USD)
Table 24. Global Anthrax Vaccines Sales (Kilotons) by Type (2019-2024)
Table 25. Global Anthrax Vaccines Sales Market Share by Type (2019-2024)
Table 26. Global Anthrax Vaccines Market Size (M USD) by Type (2019-2024)
Table 27. Global Anthrax Vaccines Market Size Share by Type (2019-2024)
Table 28. Global Anthrax Vaccines Price (USD/Ton) by Type (2019-2024)
Table 29. Global Anthrax Vaccines Sales (Kilotons) by Application
Table 30. Global Anthrax Vaccines Market Size by Application
Table 31. Global Anthrax Vaccines Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Anthrax Vaccines Sales Market Share by Application (2019-2024)
Table 33. Global Anthrax Vaccines Sales by Application (2019-2024) & (M USD)
Table 34. Global Anthrax Vaccines Market Share by Application (2019-2024)
Table 35. Global Anthrax Vaccines Sales Growth Rate by Application (2019-2024)
Table 36. Global Anthrax Vaccines Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Anthrax Vaccines Sales Market Share by Region (2019-2024)
Table 38. North America Anthrax Vaccines Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Anthrax Vaccines Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Anthrax Vaccines Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Anthrax Vaccines Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Anthrax Vaccines Sales by Region (2019-2024) & (Kilotons)
Table 43. Emergent BioSolutions Anthrax Vaccines Basic Information
Table 44. Emergent BioSolutions Anthrax Vaccines Product Overview
Table 45. Emergent BioSolutions Anthrax Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Emergent BioSolutions Business Overview
Table 47. Emergent BioSolutions Anthrax Vaccines SWOT Analysis
Table 48. Emergent BioSolutions Recent Developments
Table 49. Merial Anthrax Vaccines Basic Information
Table 50. Merial Anthrax Vaccines Product Overview
Table 51. Merial Anthrax Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Merial Business Overview
Table 53. Merial Anthrax Vaccines SWOT Analysis
Table 54. Merial Recent Developments
Table 55. Merck Anthrax Vaccines Basic Information
Table 56. Merck Anthrax Vaccines Product Overview
Table 57. Merck Anthrax Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Merck Anthrax Vaccines SWOT Analysis
Table 59. Merck Business Overview
Table 60. Merck Recent Developments
Table 61. Zoetis Anthrax Vaccines Basic Information
Table 62. Zoetis Anthrax Vaccines Product Overview
Table 63. Zoetis Anthrax Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Zoetis Business Overview
Table 65. Zoetis Recent Developments
Table 66. Bayer Sanidad Animal Anthrax Vaccines Basic Information
Table 67. Bayer Sanidad Animal Anthrax Vaccines Product Overview
Table 68. Bayer Sanidad Animal Anthrax Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Bayer Sanidad Animal Business Overview
Table 70. Bayer Sanidad Animal Recent Developments
Table 71. Colorado Serum Anthrax Vaccines Basic Information
Table 72. Colorado Serum Anthrax Vaccines Product Overview
Table 73. Colorado Serum Anthrax Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Colorado Serum Business Overview
Table 75. Colorado Serum Recent Developments
Table 76. PharmAthene Anthrax Vaccines Basic Information
Table 77. PharmAthene Anthrax Vaccines Product Overview
Table 78. PharmAthene Anthrax Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. PharmAthene Business Overview
Table 80. PharmAthene Recent Developments
Table 81. Tiankang Anthrax Vaccines Basic Information
Table 82. Tiankang Anthrax Vaccines Product Overview
Table 83. Tiankang Anthrax Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Tiankang Business Overview
Table 85. Tiankang Recent Developments
Table 86. Biog?nesis-Bago Anthrax Vaccines Basic Information
Table 87. Biog?nesis-Bago Anthrax Vaccines Product Overview
Table 88. Biog?nesis-Bago Anthrax Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Biog?nesis-Bago Business Overview
Table 90. Biog?nesis-Bago Recent Developments
Table 91. CAVAC Anthrax Vaccines Basic Information
Table 92. CAVAC Anthrax Vaccines Product Overview
Table 93. CAVAC Anthrax Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. CAVAC Business Overview
Table 95. CAVAC Recent Developments
Table 96. Rosenbusch Anthrax Vaccines Basic Information
Table 97. Rosenbusch Anthrax Vaccines Product Overview
Table 98. Rosenbusch Anthrax Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Rosenbusch Business Overview
Table 100. Rosenbusch Recent Developments
Table 101. Agrovet Anthrax Vaccines Basic Information
Table 102. Agrovet Anthrax Vaccines Product Overview
Table 103. Agrovet Anthrax Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Agrovet Business Overview
Table 105. Agrovet Recent Developments
Table 106. Vecol Anthrax Vaccines Basic Information
Table 107. Vecol Anthrax Vaccines Product Overview
Table 108. Vecol Anthrax Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Vecol Business Overview
Table 110. Vecol Recent Developments
Table 111. CVCRI Anthrax Vaccines Basic Information
Table 112. CVCRI Anthrax Vaccines Product Overview
Table 113. CVCRI Anthrax Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. CVCRI Business Overview
Table 115. CVCRI Recent Developments
Table 116. IVPM Anthrax Vaccines Basic Information
Table 117. IVPM Anthrax Vaccines Product Overview
Table 118. IVPM Anthrax Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. IVPM Business Overview
Table 120. IVPM Recent Developments
Table 121. Prondil Anthrax Vaccines Basic Information
Table 122. Prondil Anthrax Vaccines Product Overview
Table 123. Prondil Anthrax Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Prondil Business Overview
Table 125. Prondil Recent Developments
Table 126. CDV Anthrax Vaccines Basic Information
Table 127. CDV Anthrax Vaccines Product Overview
Table 128. CDV Anthrax Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. CDV Business Overview
Table 130. CDV Recent Developments
Table 131. Indian Immunologicals Anthrax Vaccines Basic Information
Table 132. Indian Immunologicals Anthrax Vaccines Product Overview
Table 133. Indian Immunologicals Anthrax Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. Indian Immunologicals Business Overview
Table 135. Indian Immunologicals Recent Developments
Table 136. Botswana Vaccine Institute Anthrax Vaccines Basic Information
Table 137. Botswana Vaccine Institute Anthrax Vaccines Product Overview
Table 138. Botswana Vaccine Institute Anthrax Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 139. Botswana Vaccine Institute Business Overview
Table 140. Botswana Vaccine Institute Recent Developments
Table 141. Ceva Sant? Animale Anthrax Vaccines Basic Information
Table 142. Ceva Sant? Animale Anthrax Vaccines Product Overview
Table 143. Ceva Sant? Animale Anthrax Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 144. Ceva Sant? Animale Business Overview
Table 145. Ceva Sant? Animale Recent Developments
Table 146. Intervac Anthrax Vaccines Basic Information
Table 147. Intervac Anthrax Vaccines Product Overview
Table 148. Intervac Anthrax Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 149. Intervac Business Overview
Table 150. Intervac Recent Developments
Table 151. JOVAC Anthrax Vaccines Basic Information
Table 152. JOVAC Anthrax Vaccines Product Overview
Table 153. JOVAC Anthrax Vaccines Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 154. JOVAC Business Overview
Table 155. JOVAC Recent Developments
Table 156. Global Anthrax Vaccines Sales Forecast by Region (2025-2030) & (Kilotons)
Table 157. Global Anthrax Vaccines Market Size Forecast by Region (2025-2030) & (M USD)
Table 158. North America Anthrax Vaccines Sales Forecast by Country (2025-2030) & (Kilotons)
Table 159. North America Anthrax Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 160. Europe Anthrax Vaccines Sales Forecast by Country (2025-2030) & (Kilotons)
Table 161. Europe Anthrax Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 162. Asia Pacific Anthrax Vaccines Sales Forecast by Region (2025-2030) & (Kilotons)
Table 163. Asia Pacific Anthrax Vaccines Market Size Forecast by Region (2025-2030) & (M USD)
Table 164. South America Anthrax Vaccines Sales Forecast by Country (2025-2030) & (Kilotons)
Table 165. South America Anthrax Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 166. Middle East and Africa Anthrax Vaccines Consumption Forecast by Country (2025-2030) & (Units)
Table 167. Middle East and Africa Anthrax Vaccines Market Size Forecast by Country (2025-2030) & (M USD)
Table 168. Global Anthrax Vaccines Sales Forecast by Type (2025-2030) & (Kilotons)
Table 169. Global Anthrax Vaccines Market Size Forecast by Type (2025-2030) & (M USD)
Table 170. Global Anthrax Vaccines Price Forecast by Type (2025-2030) & (USD/Ton)
Table 171. Global Anthrax Vaccines Sales (Kilotons) Forecast by Application (2025-2030)
Table 172. Global Anthrax Vaccines Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Anthrax Vaccines
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Anthrax Vaccines Market Size (M USD), 2019-2030
Figure 5. Global Anthrax Vaccines Market Size (M USD) (2019-2030)
Figure 6. Global Anthrax Vaccines Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Anthrax Vaccines Market Size by Country (M USD)
Figure 11. Anthrax Vaccines Sales Share by Manufacturers in 2023
Figure 12. Global Anthrax Vaccines Revenue Share by Manufacturers in 2023
Figure 13. Anthrax Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Anthrax Vaccines Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Anthrax Vaccines Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Anthrax Vaccines Market Share by Type
Figure 18. Sales Market Share of Anthrax Vaccines by Type (2019-2024)
Figure 19. Sales Market Share of Anthrax Vaccines by Type in 2023
Figure 20. Market Size Share of Anthrax Vaccines by Type (2019-2024)
Figure 21. Market Size Market Share of Anthrax Vaccines by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Anthrax Vaccines Market Share by Application
Figure 24. Global Anthrax Vaccines Sales Market Share by Application (2019-2024)
Figure 25. Global Anthrax Vaccines Sales Market Share by Application in 2023
Figure 26. Global Anthrax Vaccines Market Share by Application (2019-2024)
Figure 27. Global Anthrax Vaccines Market Share by Application in 2023
Figure 28. Global Anthrax Vaccines Sales Growth Rate by Application (2019-2024)
Figure 29. Global Anthrax Vaccines Sales Market Share by Region (2019-2024)
Figure 30. North America Anthrax Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Anthrax Vaccines Sales Market Share by Country in 2023
Figure 32. U.S. Anthrax Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Anthrax Vaccines Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Anthrax Vaccines Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Anthrax Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Anthrax Vaccines Sales Market Share by Country in 2023
Figure 37. Germany Anthrax Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Anthrax Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Anthrax Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Anthrax Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Anthrax Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Anthrax Vaccines Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Anthrax Vaccines Sales Market Share by Region in 2023
Figure 44. China Anthrax Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Anthrax Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Anthrax Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Anthrax Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Anthrax Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Anthrax Vaccines Sales and Growth Rate (Kilotons)
Figure 50. South America Anthrax Vaccines Sales Market Share by Country in 2023
Figure 51. Brazil Anthrax Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Anthrax Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Anthrax Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Anthrax Vaccines Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Anthrax Vaccines Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Anthrax Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Anthrax Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Anthrax Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Anthrax Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Anthrax Vaccines Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Anthrax Vaccines Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Anthrax Vaccines Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Anthrax Vaccines Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Anthrax Vaccines Market Share Forecast by Type (2025-2030)
Figure 65. Global Anthrax Vaccines Sales Forecast by Application (2025-2030)
Figure 66. Global Anthrax Vaccines Market Share Forecast by Application (2025-2030)
